|
glaucoma |
10 |
|
retinal ganglion cell |
10 |
|
alzheimer's disease |
9 |
|
retina |
8 |
|
aging |
6 |
|
electrical stimulation |
6 |
|
lycium barbarum |
6 |
|
microglia |
6 |
|
neuroinflammation |
6 |
|
rat |
6 |
|
amyloid-β |
5 |
|
axonal injury |
5 |
|
axonal regeneration |
5 |
|
endothelin-1 |
5 |
|
lycium barbarum polysaccharides |
5 |
|
motoneuron |
5 |
|
mouse |
5 |
|
neuroprotection |
5 |
|
retinal ganglion cells |
5 |
|
transcription factor |
5 |
|
wolfberry |
5 |
|
alzheimer’s disease |
4 |
|
animals |
4 |
|
antioxidant |
4 |
|
disease models, animal |
4 |
|
electrical phosphene threshold |
4 |
|
induced pluripotent stem cell derived-mesenchymal stem cell |
4 |
|
inflammation |
4 |
|
intraocular pressure |
4 |
|
mitochondrial defect |
4 |
|
mitochondrial transfer |
4 |
|
neurodegeneration |
4 |
|
neuroscience |
4 |
|
retinal degeneration |
4 |
|
visual function |
4 |
|
8-ohg |
3 |
|
administration, oral |
3 |
|
age-related macular degeneration |
3 |
|
alzheimer disease |
3 |
|
alzheimer's disease. |
3 |
|
animal experiment |
3 |
|
anti-inflammatory factors |
3 |
|
artesunate |
3 |
|
blotting, western |
3 |
|
brain |
3 |
|
brain diseases - immunology - physiopathology - therapy |
3 |
|
calpain-2 |
3 |
|
calpain-5 |
3 |
|
cataract surgery |
3 |
|
cell shape |
3 |
|
cell size |
3 |
|
cell survival - drug effects |
3 |
|
central nervous system - cytology - immunology - metabolism |
3 |
|
chemokine ccl2 - immunology |
3 |
|
chronic disease |
3 |
|
cigarette smoking |
3 |
|
combination therapy |
3 |
|
crystallin |
3 |
|
crystallins - metabolism |
3 |
|
cytoskeleton |
3 |
|
dentate gyrus |
3 |
|
dissection |
3 |
|
drugs, chinese herbal - pharmacology - therapeutic use |
3 |
|
electrical stimulation (es) |
3 |
|
electrophoresis, gel, two-dimensional |
3 |
|
epithelial-mesenchymal transition |
3 |
|
experimental glaucoma |
3 |
|
eye |
3 |
|
female |
3 |
|
functional recovery |
3 |
|
glaucoma - immunology - pathology |
3 |
|
glaucoma - physiopathology |
3 |
|
glaucoma. |
3 |
|
humans |
3 |
|
hydrophobic acrylic |
3 |
|
igf-1 |
3 |
|
immune system processes - immunology |
3 |
|
immunohistochemistry |
3 |
|
immunotherapy |
3 |
|
inflammation - immunology - physiopathology - prevention & control |
3 |
|
injection |
3 |
|
inner nuclear layer |
3 |
|
insulin-like growth factor i/immunology |
3 |
|
intraocular lens |
3 |
|
issue 10 |
3 |
|
issue 16 |
3 |
|
issue 60 |
3 |
|
l. barbarum |
3 |
|
laser coagulation |
3 |
|
lasers |
3 |
|
lycium - chemistry |
3 |
|
lycium barbarum extract |
3 |
|
m1 microglia |
3 |
|
m2 microglia |
3 |
|
macrophage |
3 |
|
mcp-1/ccl2 |
3 |
|
medical sciences |
3 |
|
microglia - immunology - pathology |
3 |
|
morphometric analysis |
3 |
|
nerve degeneration - drug therapy - etiology - physiopathology |
3 |
|
neural cell adhesion molecule |
3 |
|
neurofibrillary tangles |
3 |
|
neuroglia - immunology - metabolism |
3 |
|
neuroimmunomodulation |
3 |
|
neuroprotective agents - pharmacology |
3 |
|
neuroprotective agents - pharmacology - therapeutic use |
3 |
|
neurotrophins |
3 |
|
ocular hypertension |
3 |
|
ocular hypertension - etiology |
3 |
|
ocular hypertension - pathology - physiopathology |
3 |
|
ocular hypertension - physiopathology |
3 |
|
ophthalmology research |
3 |
|
optic nerve (on) |
3 |
|
partial transection |
3 |
|
plant extracts - pharmacology |
3 |
|
plaques |
3 |
|
potassium ions |
3 |
|
proinflammatory factors |
3 |
|
psychiatry and neurology gerontology and geriatrics |
3 |
|
rats |
3 |
|
rats, sprague-dawley |
3 |
|
retina -- diseases. |
3 |
|
retinal degeneration - drug therapy - etiology - physiopathology |
3 |
|
retinal ganglion cells - drug effects - metabolism |
3 |
|
retinal ganglion cells - drug effects - pathology |
3 |
|
retinal vein occlusion - etiology - physiopathology |
3 |
|
retrograde labeling |
3 |
|
safety |
3 |
|
secondary degeneration |
3 |
|
signal transduction - immunology |
3 |
|
stereo investigator |
3 |
|
superior colliculus |
3 |
|
synapse |
3 |
|
tau phosphorylation |
3 |
|
thickness |
3 |
|
treatment outcome |
3 |
|
up-regulation |
3 |
|
5xfad mice |
2 |
|
adult endogenous neurogenesis |
2 |
|
alzheimer's pathology |
2 |
|
alzheimer-like pathology |
2 |
|
amyloid peptide |
2 |
|
angiogenesis |
2 |
|
antiaging |
2 |
|
artemisinin |
2 |
|
autophagy |
2 |
|
axon regeneration |
2 |
|
aβ deposit |
2 |
|
aβ deposition |
2 |
|
basic fibroblast growth factor-chitosan gel |
2 |
|
brain - physiology |
2 |
|
caenorhabditis elegans |
2 |
|
calcitriol |
2 |
|
calcium |
2 |
|
calcium channel blockers |
2 |
|
carbon nanotubes |
2 |
|
cell survival |
2 |
|
central nervous system |
2 |
|
chat staining |
2 |
|
chemokines. |
2 |
|
chinese herbal medicine |
2 |
|
chitosan |
2 |
|
complement factors |
2 |
|
computational retinal microvasculature biomarkers (crmb) |
2 |
|
cornea |
2 |
|
crystalline lens. |
2 |
|
cytokines |
2 |
|
cytokines - physiology |
2 |
|
delirium |
2 |
|
delirium - physiopathology |
2 |
|
depression |
2 |
|
differentiation |
2 |
|
electric stimulation |
2 |
|
eye diseases |
2 |
|
glaucoma - immunological aspects. |
2 |
|
glaucoma - metabolism - pathology |
2 |
|
glutamate receptor |
2 |
|
health span |
2 |
|
human tenon’s fibroblasts (htf) |
2 |
|
illness behavior - physiology |
2 |
|
immunomodulation |
2 |
|
inflammation - physiopathology |
2 |
|
intraocular pressure - physiology |
2 |
|
ischemic stroke |
2 |
|
light coagulation |
2 |
|
lycium barbarum glycopeptide |
2 |
|
lycium chinense - therapeutic use. |
2 |
|
lycium ruthenicum murray |
2 |
|
microglia-related targets |
2 |
|
microglia. |
2 |
|
microscopy, confocal |
2 |
|
mitochondria |
2 |
|
mitochondrial drug delivery system |
2 |
|
motor neuron |
2 |
|
mouse primary brain glial cells |
2 |
|
multi-electrode array |
2 |
|
nature products |
2 |
|
neonatal |
2 |
|
nerve injury |
2 |
|
neural stem cell |
2 |
|
neurohormones |
2 |
|
neuroimmune activation |
2 |
|
neuroprotective microglial phenotype |
2 |
|
newborn neuron |
2 |
|
ophthalmology |
2 |
|
optic neuropathy |
2 |
|
optical coherence tomography angiography (octa) |
2 |
|
oxidative stress |
2 |
|
parkinson’s disease |
2 |
|
peripheral nerve |
2 |
|
phagocytosis |
2 |
|
photoreceptor degeneration |
2 |
|
polysaccharide |
2 |
|
prostaglandins |
2 |
|
protein kinase r |
2 |
|
pterygium |
2 |
|
receptors, ampa - metabolism |
2 |
|
receptors, n-methyl-d-aspartate - metabolism |
2 |
|
regeneration |
2 |
|
retinal ganglion cells - metabolism - pathology |
2 |
|
retinal ganglion cells. |
2 |
|
retinal imaging |
2 |
|
retinal vein occlusion |
2 |
|
retinitis pigmentosa |
2 |
|
rna sequencing |
2 |
|
selective vulnerability |
2 |
|
sickness |
2 |
|
sickness behavior |
2 |
|
sickness response |
2 |
|
spinal cord |
2 |
|
spinal cord injury |
2 |
|
systemic inflammation |
2 |
|
tau |
2 |
|
tau deposit |
2 |
|
visual system |
2 |
|
wnt pathway |
2 |
|
枸杞多糖 |
2 |
|
神经保护 |
2 |
|
视网膜退行性疾病 |
2 |
|
aging brain |
1 |
|
apoptosis |
1 |
|
axon myelination |
1 |
|
biocompatible material (生物相容性材料) |
1 |
|
bioelectrode |
1 |
|
calpain |
1 |
|
capsule opacification/etiolo (囊膜混濁/病因) |
1 |
|
chronic ocular hypertension |
1 |
|
conductive nanomaterials |
1 |
|
corneal nerves |
1 |
|
cx3cr1 |
1 |
|
designer self-assembling peptide |
1 |
|
drug delivery |
1 |
|
electrical fields |
1 |
|
electrochemical sensor |
1 |
|
electromagnetic fields |
1 |
|
epithelial cells, lens (晶狀體上皮細胞) |
1 |
|
eye cancer |
1 |
|
frontal cortex |
1 |
|
ganglion cell |
1 |
|
hippocampus |
1 |
|
in vivo |
1 |
|
injectability |
1 |
|
lenses, intraocular/adverse effects (人工晶狀體/不良反應) |
1 |
|
long-term potentiation |
1 |
|
mouse model |
1 |
|
multielectrode array |
1 |
|
myopia |
1 |
|
neural stem cells |
1 |
|
neurites outgrowth |
1 |
|
nmda |
1 |
|
pda@cnts−pedot |
1 |
|
photoreceptor |
1 |
|
posterior capsule of the lens/pathology (晶狀體後囊膜/病理) |
1 |
|
proteinases |
1 |
|
refractive surgery |
1 |
|
rodent models |
1 |
|
synaptic homeostasis |
1 |
|
五輪八廓學說 |
1 |
|
假說 |
1 |
|
电刺激 |
1 |
|
神经再生 |
1 |
|
視網膜靜脈阻塞 |
1 |
|
视神经 |
1 |
|
视网膜 |
1 |
|
黃斑八廓 |
1 |
|
黃斑視功能 |
1 |
